Reducing Complexity Helps Weleda Break Sales Record

Swiss firm reports highest revenues in its history as restructure pays off for its pharma and cosmetics businesses in 2024.

(Shutterstock)

Restructuring the business to give its pharma and cosmetics operations “greater entrepreneurial responsibility” paid off for Weleda in 2024 as the Swiss firm reported the highest revenues in its 100+ year history.

Group sales advanced by 8.3% to €456m ($501m) in the year Weleda introduced its dedicated Natural Cosmetics and Pharmaceuticals business units

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Earnings

Recordati Relying On OTC To Act As ‘Booster’ To Growth

 
• By 

In categories like cough & cold and gastrointestinal, OTC products have a pivotal role to play in helping Recordati hit its sales targets for the 2025-2027 period.

Bayer Consumer Health Delivers ‘Balanced’ Q1

 
• By 

With sales gains across most of its regions and product categories, Bayer Consumer Health got off to a good start to the year.

Mitigating Tariff Impacts, Kenvue Adjusts Outlook

 

“The situation has evolved considerably” since Kenvue gave its initial full-year outlook in February, “and remains quite fluid,” says president and CEO Thibaut Mongon as firm reports Q1 net sales decreasing 3.9% to $3.7bn

Looming Tariffs Give Boost To Latest PCH Results While Cutting Costs In Response Takes Priority

 

Looming imposition of tariffs by Trump on imports from most every country had an influence on consumers during the January-March period, particularly on online shopping. Increasing product prices on the table, “but our efforts are going to start with cost savings,” says CFO Christine Sacco.

More from Beauty